Medicare Enrolled
Dr. Michael Maccini, M.D.
Urology Physician · Spokane, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Maccini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maccini?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maccini
Dr. Michael Maccini is an urology physician in Spokane, WA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Maccini performed 5,145 Medicare services across 1,897 unique beneficiaries.
Between the years covered by Open Payments, Dr. Maccini received a total of $10,441 from 47 pharmaceutical and/or device companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maccini is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 13% volume in WA
$10,441 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,145
Medicare services
Top 13% in WA for urology physician
1,897
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~368 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
2,900 | $5 | $10 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
362 | $3 | $33 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
338 | $63 | $167 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
283 | $8 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
195 | $82 | $242 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
156 | $160 | $513 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
124 | $720 | $1,696 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
91 | $118 | $348 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
88 | $108 | $244 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
55 | $291 | $667 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
54 | $6 | $189 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
45 | $20 | $54 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
39 | $19 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
37 | $67 | $243 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
31 | $8 | $21 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
31 | $1,004 | $2,324 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
27 | $184 | $618 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
24 | $17 | $45 |
| Injection, tobramycin sulfate, up to 80 mg | 24 | $2 | $8 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
20 | $40 | $100 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
19 | $282 | $863 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $63 | $150 |
| Injection, garamycin, gentamicin, up to 80 mg | 19 | $2 | $5 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
18 | $311 | $612 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
18 | $119 | $444 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
17 | $566 | $1,800 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
16 | $586 | $1,800 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $262 | $492 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
15 | $12 | $88 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $104 | $300 |
| Laparoscopic partial prostate removal A minimally invasive surgical procedure to remove part of the prostate gland using a laparoscope. |
14 | $834 | $3,117 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $38 | $131 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $58 | $126 |
| PSA test (prostate cancer screening) | 11 | $18 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
66.1% medium
32.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,441
Total received (2018-2024)
Avg $1,492/year across 7 years
Top 11% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
174
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,430 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$11 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,038
2023
$644
2022
$2,172
2021
$814
2020
$337
2019
$1,675
2018
$1,762
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$1,077
Edap Technomed Inc
$687
Ferring Pharmaceuticals Inc.
$340
Sumitomo Pharma America, Inc.
$263
BLUEWIND MEDICAL
$184
UROGEN PHARMA, INC.
$162
ABBVIE INC.
$119
Laborie Medical Technologies Corp.
$48
Janssen Biotech, Inc.
$46
Verity Pharmaceuticals Inc.
$26
ACCORD HEALTHCARE, INC.
$20
Dendreon Pharmaceuticals LLC
$19
VERTEX PHARMACEUTICALS INCORPORATED
$17
Merck Sharp & Dohme LLC
$15
Olympus America Inc.
$15
Top 3 companies account for 69.3% of 2024 payments
All-time payments by company (2018-2024) ›
Teleflex LLC
$2,835
Boston Scientific Corporation
$1,420
NeoTract Inc.
$1,127
Edap Technomed Inc
$687
Janssen Biotech, Inc.
$548
Astellas Pharma US Inc
$412
Ferring Pharmaceuticals Inc.
$340
Sumitomo Pharma America, Inc.
$304
ABBVIE INC.
$272
Rochester Medical Corporation
$212
BLUEWIND MEDICAL
$184
UROGEN PHARMA, INC.
$162
Olympus America Inc.
$152
Bayer HealthCare Pharmaceuticals Inc.
$149
Palette Life Sciences, Inc.
$147
Stryker Corporation
$142
Sun Pharmaceutical Industries Inc.
$133
Endo Pharmaceuticals Inc.
$132
BOSTON SCIENTIFIC CORPORATION
$125
Allergan, Inc.
$113
Dendreon Pharmaceuticals LLC
$111
Analogic Corporation
$80
Caldera Medical, Inc
$80
Myriad Genetic Laboratories, Inc.
$65
ACCORD HEALTHCARE, INC.
$50
AbbVie Inc.
$49
Laborie Medical Technologies Corp.
$48
Baxter Healthcare
$45
Blue Earth Diagnostics Limited
$27
Verity Pharmaceuticals Inc.
$26
Novartis Pharmaceuticals Corporation
$23
Coloplast Corp
$21
Tolmar, Inc.
$18
CONMED Corporation
$18
VERTEX PHARMACEUTICALS INCORPORATED
$17
UROVANT SCIENCES INC
$17
COLOPLAST CORP
$16
Merck Sharp & Dohme LLC
$15
Hollister Incorporated
$14
Alnylam Pharmaceuticals Inc.
$14
Antares Pharma, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$14
Ambu Inc.
$13
Allergan Inc.
$12
Photocure Inc
$12
Travere Therapeutics, Inc.
$11
Cook Medical LLC
$11
Top 3 companies account for 51.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ADVANCE · AIRSEAL · AMS · Axumin · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · BRACAnalysis CDx · CAMCEVI · COOK MEDICAL DILATION/ACCESS · Coloplast TFL Drive · Cysview · Desara · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL - ONCOLOGY · GENERAL ERECTILE DYSFUNCTION · GENERAL KIDNEY STONE DISEASE · GENERAL THERAPIES · Infyna Chic · JELMYTO · KEYTRUDA · LUPRON DEPOT · MYRBETRIQ · Myrbetriq · NEW PRODUCT DEVELOPMENT · NOCDURNA · Nubeqa · ORGOVYX · OXLUMO · Olympus Cystoscopes · Olympus Laser Devices · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PROVENGE · Prolaris · REVI · REZUM · SOLTIVE · Seglentis · TISSEEL · Thiola · Titan · Trelstar · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · Xofigo · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
23
Per 100K population
4.2
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Maccini is a mixed practice specialist, with above-average Medicare volume (top 13% in WA), with low-engagement industry engagement in the top 11% of WA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Maccini experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Maccini performed 2,900 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maccini receive payments from pharmaceutical companies?
Yes. Dr. Maccini received a total of $10,441 from 47 companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maccini's costs compare to other urology physicians in Spokane?
Dr. Maccini's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maccini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Spokane
Browse urology physicians in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in WA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in WA
Which WA urology physicians receive the most from drug and device companies.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology